Drug
18F-PF-06445974
18F-PF-06445974 is a pharmaceutical drug with 3 clinical trials. Currently 3 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
3(100%)
Phase Distribution
Ph phase_1
3
100%
Phase Distribution
3
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
3(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
3
trials recruiting
Total Trials
3
all time
Status Distribution
Active(3)
Detailed Status
Recruiting3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
3
Success Rate
N/A
Most Advanced
Phase 1
Trials by Phase
Phase 13 (100.0%)
Trials by Status
recruiting3100%
Recent Activity
3 active trials
Showing 3 of 3
Clinical Trials (3)
Showing 3 of 3 trials
NCT05703685Phase 1
[18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET
NCT06795581Phase 1
PET Imaging of Phosphodiesterase-4B (PDE4B) in Alcohol Use Disorder
NCT07027839Phase 1
Acute Effects of Alcohol on PET Imaging of Phosphodiesterase-4B (PDE4B)
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3